Cite

HARVARD Citation

    Ohlsson, T. et al. (n.d.). Midregional proadrenomedullin predicts reduced blood pressure and glucose elevation over time despite enhanced progression of obesity markers. Journal of hypertension. 37 (3), p. . [Online]. 
  
Back to record